Contact Us

The choice depends on whether you are studying GCH1 (GTP cyclohydrolase 1)'s role as the rate-limiting enzyme of tetrahydrobiopterin (BH4) biosynthesis or modeling dopa-responsive dystonia (Segawa syndrome) and chronic pain GWAS associations. The Knockout line is the standard tool for asking whether GCH1 is required for these processes — GCH1 catalyzes the first and rate-limiting step of de novo BH4 biosynthesis (GTP → 7,8-dihydroneopterin triphosphate), generating BH4 as an essential cofactor for aromatic amino acid hydroxylases (PAH, TH, TPH), nitric oxide synthases (NOS), and alkylglycerol monooxygenase. Overexpression is useful for studying GCH1 gain-of-function effects. For BH4 biology research, the EDITGENE GCH1 Knockout in HaCaT is informative — HaCaT is a human keratinocyte cell line, providing a skin/peripheral context for BH4 metabolism research. GCH1 dominant-negative mutations cause dopa-responsive dystonia (Segawa syndrome, autosomal dominant DOPA-responsive dystonia); GCH1 polymorphisms are associated with chronic pain susceptibility (one of the strongest pain GWAS loci). Rescue with wild-type or catalytically-dead GCH1 enables structure-function studies. The knockout is valuable for studying BH4-dependent enzymes (NOS, aromatic amino acid hydroxylases), dopa-responsive dystonia, and emerging BH4-related therapeutics (sapropterin/Kuvan for PKU).

Yes. GCH1 rescue experiments are well-established for BH4 biology research: • Construct design: use a codon-modified GCH1 sequence with a small C-terminal tag (FLAG, HA). GCH1 functions as a homodecamer (two homopentamers) — preserve oligomerization-relevant regions. • Catalytically-dead rescue: active site residue mutations abolish GTP cyclohydrolase activity and serve as the standard specificity control. • Dopa-responsive dystonia mutation rescue: patient-derived dominant-negative GCH1 mutations enable disease genotype-function studies. • Pain GWAS variant rescue: pain-associated GCH1 polymorphisms enable pharmacogenomic studies. • Functional readout: rescue should restore cellular BH4 levels measured by HPLC and downstream NOS/aromatic amino acid hydroxylase function. HaCaT-specific considerations: • HaCaT is a spontaneously immortalized human keratinocyte cell line widely used for skin biology, wound healing, and keratinocyte differentiation research. • Lentiviral transduction efficiency is moderate; standard keratinocyte culture conditions are required. • HaCaT retains many keratinocyte features but may differ from primary keratinocytes in some respects — confirm relevant phenotypes in primary models when possible.

Yes. HIF1A rescue experiments in HEK293T are well-suited for systematic structure-function research: • Construct design: use a codon-modified HIF1A sequence with a small C-terminal tag (FLAG, HA). HIF1α has N-terminal bHLH-PAS (DNA binding/dimerization), central ODD (oxygen-dependent degradation) with P402/P564 hydroxylation sites, NTAD/CTAD transactivation domains — preserve all elements. • Constitutively stable rescue: P402A/P564A double mutation bypasses PHD-VHL degradation, generating constitutively active HIF1α — invaluable for separating hypoxia-induced from constitutive HIF1α functions. • DNA-binding-deficient rescue: bHLH basic region mutations abolish HRE binding. • Functional readout: rescue should restore hypoxia-induced HIF target gene expression. HEK293T transduces with very high efficiency and supports systematic structure-function rescue experiments.

The choice depends on whether you are studying HCK (hematopoietic cell kinase)'s role as a Src-family kinase in myeloid cell signaling or its functions in cancer and CML therapy resistance. The Knockout line is the standard tool for asking whether HCK is required for these processes — HCK is a Src-family tyrosine kinase principally expressed in myeloid cells (macrophages, neutrophils, dendritic cells) and B cells, with established roles in phagocytosis, integrin signaling, and BCR-ABL-driven CML. Overexpression is useful for studying HCK gain-of-function in cancer contexts. Important consideration: Src-family kinases (SRC, LYN, FYN, YES, FGR, HCK, LCK, BLK) share substantial substrate scope — single HCK knockout in HAP1 may show modest phenotypes if other Src-family members compensate. This product complements the parallel LYN Knockout in HAP1 (also available) for Src-family functional dissection in myeloid context. Rescue with wild-type, kinase-dead, or Y505F (autoinhibitory phospho-site mutant, constitutively active) HCK is the standard specificity control. The knockout is valuable for studying CML imatinib resistance (HCK overexpression has been implicated) and BCR-ABL-driven leukemia mechanisms.

Yes. HCK rescue experiments require attention to Src-family architecture and lipid modifications: • Construct design: use a codon-modified HCK sequence with a small C-terminal tag (FLAG, HA). HCK has N-terminal myristoylation/palmitoylation, SH3, SH2, kinase domain, and C-terminal Y523 regulatory tail — preserve N-terminus for proper membrane targeting. • Kinase-dead rescue: K269A mutation in the ATP-binding lysine abolishes catalytic activity. • Constitutively active rescue: Y523F mutation removes the autoinhibitory C-terminal phosphorylation site, generating constitutively active HCK. • Lipid-modification-deficient rescue: G2A mutation abolishes myristoylation and membrane association. • Functional readout: rescue should restore Src-family kinase substrate phosphorylation patterns. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.

The choice depends on whether you are studying FN1 (fibronectin 1)'s role as the principal extracellular matrix glycoprotein or modeling its functions in cell adhesion, migration, and ECM organization. The Knockout line is the standard tool for asking whether FN1 is required for these processes — FN1 is a large (~250 kDa) secreted glycoprotein that polymerizes into fibrils, binds integrins (α5β1, αvβ3, others) through RGD motifs, and serves as the principal ECM scaffold for cell adhesion, migration, and tissue assembly during development and wound healing. Overexpression is useful for studying FN1 in heterologous expression contexts. For ECM and adhesion research, the EDITGENE FN1 Knockout in HAP1 enables study of fibronectin biology. Rescue with full-length or domain-truncated FN1 (large gene rescue is technically challenging — multiple FN1 isoforms exist through alternative splicing) enables structure-function studies. The knockout is valuable for studying integrin-FN1 interactions, fibronectin matrix assembly, and emerging FN1-targeted therapeutics in cancer and fibrosis.

Yes, with significant technical considerations for this large protein: • Construct design: FN1 encodes a ~250 kDa secreted protein from a ~10 kb cDNA — full-length cDNA rescue is technically challenging. Multiple FN1 isoforms exist through alternative splicing (EDA+/EDB+/V-region variants) — choose the isoform appropriate to the experimental question. • Domain-focused rescue: specific FN1 domain fragments (RGD-containing III10, syndecan-binding III13, etc.) can be rescued separately for structure-function studies. • Surface FN1 deposition: confirm fibronectin matrix assembly by IF staining after rescue. • Functional readout: rescue should restore cell adhesion to FN1 substrate and integrin-mediated signaling. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.

The choice depends on whether you are studying FADS1 (Δ5-desaturase, fatty acid desaturase 1)'s role as a critical enzyme in long-chain polyunsaturated fatty acid (LC-PUFA) biosynthesis or modeling FADS1 polymorphism effects on PUFA metabolism. The Knockout line is the standard tool for asking whether FADS1 is required for these processes — FADS1 catalyzes the Δ5-desaturation step in PUFA biosynthesis, converting dihomo-γ-linolenic acid (DGLA, 20:3n-6) to arachidonic acid (AA, 20:4n-6) in the ω-6 pathway and eicosatetraenoic acid (ETA, 20:4n-3) to eicosapentaenoic acid (EPA, 20:5n-3) in the ω-3 pathway. Overexpression is useful for studying FADS1 gain-of-function effects. For lipid metabolism research, the EDITGENE FADS1 Knockout in HAP1 enables study of LC-PUFA biosynthesis. This product complements the parallel FADS2 Knockout in HEK293 (also available) for complete dissection of the Δ5/Δ6-desaturase axis. FADS1 polymorphisms (the FADS1-FADS2 gene cluster on chr 11) are among the strongest genetic predictors of human serum PUFA composition. Rescue with wild-type or catalytically-dead FADS1 enables structure-function studies. The knockout is valuable for studying ω-3/ω-6 PUFA pathway dynamics and FADS polymorphism pharmacogenomic research.

Yes. FADS1 rescue experiments require attention to ER membrane targeting: • Construct design: use a codon-modified FADS1 sequence with a small C-terminal tag (FLAG, HA). FADS1 has N-terminal cytochrome b5-like domain, central diiron-binding catalytic region, and ER membrane-anchoring hydrophobic regions — preserve all elements. • ER localization validation: confirm endoplasmic reticulum localization before functional assays. • Catalytically-dead rescue: histidine cluster mutations affecting Fe coordination abolish desaturase activity. • Polymorphism rescue: FADS1 polymorphic variants enable pharmacogenomic studies. • Functional readout: rescue should restore Δ5-desaturation activity measured by ¹³C-DGLA conversion to AA or ETA conversion to EPA. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.

The choice depends on whether you are studying CYBB (gp91phox, NOX2)'s role as the catalytic membrane subunit of the phagocyte NADPH oxidase or modeling chronic granulomatous disease (CGD). The Knockout line is the standard tool for asking whether NOX2 is required for the phagocyte respiratory burst — CYBB is the principal membrane subunit of the NOX2 NADPH oxidase complex (with CYBA/p22phox, NCF1/p47phox, NCF2/p67phox, NCF4/p40phox, and Rac1/2), generating superoxide for pathogen killing in neutrophils, macrophages, and microglia. Overexpression is useful for studying CYBB gain-of-function effects. For phagocyte biology and CGD research, the EDITGENE CYBB Knockout in HL-60 is uniquely valuable — HL-60 is a human promyelocytic leukemia cell line that can be differentiated into neutrophil-like cells (DMSO, ATRA induction), providing the gold-standard genetic null model for phagocyte respiratory burst studies. CYBB X-linked recessive mutations cause X-linked CGD (the most common CGD form, ~70% of cases), characterized by recurrent bacterial/fungal infections and granuloma formation. Rescue with wild-type or patient-derived CYBB mutations enables disease genotype-function studies. The knockout is valuable for studying NOX2 biology, X-CGD disease modeling, and emerging therapeutic strategies including gene therapy (CYBB gene therapy clinical trials have shown promising results).

Yes. CYBB rescue experiments are well-established for CGD research: • Construct design: use a codon-modified CYBB sequence with a small intracellular C-terminal tag (FLAG, HA). CYBB/gp91phox is a six-transmembrane domain protein with N-terminal heme-binding, FAD-binding, and NADPH-binding regions — preserve membrane topology. • Surface/membrane localization validation: confirm proper membrane localization before respiratory burst assays. • Partner subunit considerations: NOX2 complex assembly requires CYBA/p22phox, NCF1/p47phox, NCF2/p67phox, NCF4/p40phox, Rac1/2 — rescue interpretation considers these subunit levels. • X-CGD patient mutation rescue: rescue with patient-derived CYBB mutations (missense, splice, truncation) enables disease genotype-function studies and gene therapy vector validation. • Functional readout: rescue should restore PMA-induced superoxide production measured by lucigenin chemiluminescence or DHE oxidation in differentiated HL-60 cells. HL-60-specific considerations: • HL-60 is a human acute promyelocytic leukemia cell line that can be induced to differentiate into neutrophil-like (DMSO, ATRA induction) or monocyte/macrophage-like (PMA, vitamin D3 induction) cells — widely used for myeloid biology, neutrophil function, and CGD research. • Lentiviral transduction is moderately efficient; characterize differentiation state and myeloid markers before phenotypic assays. • HL-60 neutrophil-like differentiation enables study of NADPH oxidase respiratory burst, which is the canonical CYBB function.

The choice depends on the experimental question. DDIT4L (DNA damage-inducible transcript 4 like, REDD2, Rtp801L) is a paralog of DDIT4/REDD1 with characterized inhibition of mTORC1 signaling. The Knockout line is appropriate for asking whether DDIT4L is required for predicted activities — DDIT4L and DDIT4/REDD1 are stress-induced proteins that inhibit mTORC1 by activating the TSC1/TSC2 complex to inhibit Rheb GTPase; DDIT4L has been characterized in skeletal muscle biology with roles in mTOR regulation. Overexpression is useful for studying DDIT4L gain-of-function effects. For mTOR signaling research, the EDITGENE DDIT4L Knockout in HAP1 provides a clean genetic background for DDIT4L-specific functional characterization. DDIT4/REDD1 paralog expression analysis aids interpretation given functional overlap. Rescue with wild-type or TSC2-binding-deficient DDIT4L enables structure-function studies. The knockout is valuable for studying mTORC1 negative regulation and DDIT4/L paralog dissection.

Yes. DDIT4L rescue experiments require attention to mTORC1 inhibitor architecture: • Construct design: use a codon-modified DDIT4L sequence with a small C-terminal tag (FLAG, HA). DDIT4L is a small protein (~25 kDa) with TSC2-interacting region — preserve protein integrity. • TSC2-binding-deficient rescue: TSC2-interaction surface mutations disrupt mTORC1 inhibitor function. • Functional readout: rescue should restore stress-induced mTORC1 inhibition measured by phospho-S6K analysis. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.

The choice depends on whether you are studying DOK2 (downstream of tyrosine kinase 2)'s role as a Src-family kinase negative regulator or modeling its functions in lung cancer tumor suppression. The Knockout line is the standard tool for asking whether DOK2 is required for these processes — DOK2 is a member of the DOK family of adapter proteins (DOK1-7) with PH domain (membrane recruitment), PTB domain (phospho-tyrosine binding), and C-terminal proline-rich region; DOK2 functions as a negative regulator of Src-family kinase and RAS-MAPK signaling in hematopoietic and lung epithelial contexts. Overexpression is useful for studying DOK2 in heterologous expression contexts. For lung cancer research, the EDITGENE DOK2 Knockout in BEAS-2B is highly relevant — BEAS-2B is a normal human bronchial epithelial cell line, and DOK2 has been characterized as a lung tumor suppressor that is frequently lost or mutated in lung adenocarcinoma. Rescue with wild-type DOK2 is the standard specificity control. The knockout is valuable for studying DOK family adapter biology, lung tumor suppressor mechanisms, and emerging therapeutic strategies for DOK2-low lung cancers.

Yes. DOK2 rescue experiments require attention to adapter protein architecture: • Construct design: use a codon-modified DOK2 sequence with a small C-terminal tag (FLAG, HA). DOK2 has N-terminal PH domain (membrane recruitment), PTB domain (phospho-tyrosine binding), and C-terminal proline-rich region with multiple tyrosine phosphorylation sites — preserve all elements. • PH-domain-mutant rescue: PH domain mutations disrupt membrane recruitment. • PTB-domain-mutant rescue: PTB domain mutations disrupt phospho-tyrosine binding for substrate recognition studies. • Functional readout: rescue should restore SFK negative regulation and reduced phospho-ERK in lung epithelial context. BEAS-2B-specific considerations: • BEAS-2B is a SV40-immortalized normal human bronchial epithelial cell line — widely used for respiratory epithelial biology and airway disease research. • Lentiviral transduction is supported but may require optimization compared to standard transformed cell lines.